Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Expansion of Genedata’s Collaboration with Serono into High Content Screening

14.12.2006
Computational biology firm Genedata announces the expansion of its screening analysis collaboration with Serono. Scientists at Serono now use Genedata’s computational solution to combine results from high content screening assays with chemical and pharmacological information as part of the process to identify promising candidates for drug development.

High content data from cellular assay technologies used at Serono enable sophisticated biological profiling. These screening technologies provide insights into the biological effects of potential drug candidates, including possible toxic side effects.

To exploit these technologies, screening results need to be shared among people with different expertise, including chemists and toxicologists. Biopharmaceutical company Serono is familiar with this process, and is organized internally to ensure there is good communication between various expert groups.

To complement this process, Genedata’s result management and analysis solution Genedata Screener combines central database functions with interactive analysis tools and web-based access to databases. In step with recent developments in biomolecular screening, Genedata have developed a scientific platform to validate and analyze cellular assays.

During the course of the collaboration, Genedata extended its Screener solution, enabling Serono’s researchers to analyze and annotate their screening results more efficiently. The collaboration quickly reached the point where the software was a precise fit with Serono’s needs.

Scientists from Serono and Genedata co-authored a research presentation made at this year’s Society for Biomolecular Sciences annual meeting in Seattle, Washington. Genedata plays an important role in the exchange of knowledge at Serono, both internally and with the wider screening community.

The collaboration has progressed in stages since its initiation in 2003. In its current form, Genedata’s solution is compatible with Cellomics screening technologies and includes sophisticated Application Programming Interfaces (APIs), an important technology for web-based software applications.

Dr. Stephan Heyse, Head of Genedata Screener, explained, “We are very pleased with the way our solution has been adopted at Serono, not just within Serono’s IT department, but also in terms of integration with the company’s drug discovery processes”.

tobe freeman | alfa
Further information:
http://www.genedata.com/press/press_releases/2006/serono/index_eng.html

More articles from Information Technology:

nachricht Efficient time synchronization of sensor networks by means of time series analysis
24.01.2017 | Alpen-Adria-Universität Klagenfurt

nachricht Ultra-precise chip-scale sensor detects unprecedentedly small changes at the nanoscale
18.01.2017 | The Hebrew University of Jerusalem

All articles from Information Technology >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists spin artificial silk from whey protein

X-ray study throws light on key process for production

A Swedish-German team of researchers has cleared up a key process for the artificial production of silk. With the help of the intense X-rays from DESY's...

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Breaking the optical bandwidth record of stable pulsed lasers

24.01.2017 | Physics and Astronomy

Choreographing the microRNA-target dance

24.01.2017 | Life Sciences

Spanish scientists create a 3-D bioprinter to print human skin

24.01.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>